New York – Plans are progressing for the start of the annual International Pharmaceutical Expo (INTERPHEX) set for April 26 through 28 at the Jacob K. Javits Convention Center in New York City.
The exhibit and conference, sponsored by the Parenteral Drug Association (PDA), will cover product development lifecycle solutions for the pharmaceutical, biotechnology, and medical device industry to cost-effectively develop and manufacture all dosage forms.
The three-day event includes more than 300,000 square feet of exhibit space, along with comprehensive technical education sessions, a series of workshops, and opportunities for the estimated 10,000 attendees to discover partnering options and participate in networking events.
Attendees last year came from throughout the United States and 48 other countries, including Brazil, Canada, China, France, Germany, India, Italy, Mexico, and the United Kingdom.
Among the latest technology highlighted at the show this year will be the return of the special “3D Printing Demo Area,” offering an in-depth examination of 3D printing and bioprinting materials, applications for improving drug development, processing, and commercialization.
Several specific technical topics are scheduled at the 3D pavilion area during the event:
Lee Cronin, FRSE, FRSC, Regius Chair of Chemistry, at the University of Glasgow’s School of Chemistry will examine 3D Printer Inspired Chemical Robotics and the Chemical Internet, on opening day, April 26, from 10:30 am. to noon.
The session will outline Professor Cronin’s work in 3D printing of chemical reactors and reactionware to develop new systems for the potential to discover and manufacture of chemicals, including pharmaceuticals. His vision aims to combine the emergence of inexpensive robotic 3D printing, the chemical Internet, and the ability to produce chemicals in a new way potentially outside of the normal laboratory.
The following day will feature presentations by three other experts involved in developing opportunities and technical advancements in 3D designed for the pharmaceutical community.
Gautam Gupta, VP of healthcare business development at 3DSYSTEMS, will present 3D Printing: Defining New Paradigms of Design & Engineering, April 27 from 10:30 to 11:15 am.
With a special focus on applications in the healthcare industry, Gupta will discuss the value drivers of 3D printing in manufacturing, and how the technology is enabling innovation and accelerating the introduction of new products into the marketplace.
Gregory M. Paulsen, business development manager at Xometry, will follow with a presentation on 3D Printing Technologies and Applications, April 27 from 11:30 am to 12:30 pm.
Paulsen plans to address the market for 3D printed parts along with the accessibility of the technology. He will review core technologies and how they are used day-to-day to make tangible solutions for production and innovation. Special attention will be paid to the processes that are frequently used in manufacturing for sterile/medical environments.
Ricky Wildman, professor in multiphase flow and mechanics at the University of Nottingham’s Department of Chemical and Environmental Engineering, will explore 3D Printing – Creating New Ways of Manufacture and Delivery of Drugs, April 27 from 1:15 to 2 pm.
He will look at the design freedoms afforded in the pharmaceutical sector through 3D printing, allowing for creation of new methods to deliver personalized medicine and opening up new business models. But, Wildman also will explain the challenges faced in doing so—among them the need for new, safe and acceptable material choices.
Ibrahim Tarik Ozbolat, PhD, associate professor of engineering science and mechanics at Penn State University, will round out the pavilion’s Wednesday sessions with 3D Bioprinting of Living Tissues and Organs, April 27 from 2:15 to 3 pm.
Ozbolat’s presentation will demonstrate how the emerging field offers great precision for spatial placement of cells, proteins, genes, drugs and biologically active particles to better guide tissue generation and formation.
According to Ozbolat, the emerging biotechnology appears to be promising for advancing tissue engineering toward functional tissue and organ fabrication for transplantation, drug testing, research investigations, and cancer or disease modeling, and has recently attracted growing interest worldwide among researchers and the general public.
His talk will cover the working mechanism of bioprinting along with currently existing techniques, including extrusion- and inkjet-based bioprinting and its application in living tissue and organ fabrication.
All of the 3D presentations noted will take place at the “3D Printing Demo Experience” area at the show, the premier education/demo forum dedicated toward pharma and biopharma, according to organizers.
Registration for INTERPHEX 2016 can be made at http://www.interphex.com/en/Register/. Further information about the trade show, conference and exhibit hall is available by calling 888-334-8704 or 203-840-5648.
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
